Topic: Ratiopharm GmbH
Reuters US Online Report Business News | 2010-03-17 13:32:22
FRANKFURT/COLOGNE (Reuters) - The tussle over German generic drugs maker Ratiopharm is drawing to a close as the three remaining contenders square off in the final round of bidding, sources close to the deal told Reuters on Wednesday. Pfizer <PFE.N> will submit its bid on Wednesday, a person briefed on the matter said. Rival bidder Actavis of ...
Reuters US Online Report Business News | 2010-03-03 00:07:12
NEW YORK (Reuters) - Pfizer Inc <PFE.N> is set to present a nearly $4 billion offer for German generic-drug maker Ratiopharm GmbH this week, competing against rival bids from Teva Pharmaceutical Industries Ltd <TEVA.TA> and Actavis, sources familiar with the situation said on Tuesday. Pfizer had previously cooled on Ratiopharm, but was asked to rejoin ...
Reuters US Online Report Health News | 2010-02-06 15:34:21
<div><p>FRANKFURT (Reuters) - Generic-drug makers Teva and Actavis, backed by Swedish buyout firm EQT, have placed make-or-break bids for German peer Ratiopharm but drug major Pfizer is expected to also be a contender, sources said.</p><p>Ratiopharm could stay in takeover talks with two or even three bidders, as some ...
Stockhouse | 2009-05-15 16:01:50
<div id="subtitle">Company’s shares climb 75% Friday</div><div><p>Shares of Ontario-based Orbus Pharma (TSX: T.ORB, Stock Forum) jumped 75% to 10.5 cents Friday, after the company announced after Thursday’s market close that generic pharmaceutical company ratiopharm has received a Notice of Compliance from Health ...
